samedan logo
 
 
spacer
home > ict > summer 2018 > strategic selection
PUBLICATIONS
International Clinical Trials

Strategic Selection

Outsourcing in the clinical research industry continues to grow. Fifteen years ago, the top five global CROs employed 30,000 people. Now, in that group, over 100,000 individuals assist in thousands of clinical trials (1). In an era when new drug candidates are flowing into the clinical pipeline in record numbers, outsourcing is of increasing importance to the research industry. According to The Business Research Company, the global market for clinical trial services to biopharmaceutical and medical device companies is forecast to grow at 12% annually until 2021 Ė an acceleration from its increase of 10% in 2017, when its value became US $44.4 billion (2).

Multiple outsourcing models have developed to satisfy rising demand. Relationships range from full-service CROs to a variety of models with Š la carte sourcing of personnel and teams that specialise in particular functions or services. Sponsors can access highly skilled, individual consultants; augment their staff with a handful of additional lab technicians; or hire small to large functional units to fill gaps in their work capacity.

With so many choices, biopharma and biotechnology sponsors often elect to combine these options in a myriad of ways to best support their studies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jeff Mayhew is Chief Development Officer at LabConnect. As one of the partners who founded the company in 2002, Jeff has three decades of operations and business development experience within the healthcare industry. Before starting LabConnect, he was Founder and Director of Nexus Health Management International, where he was involved in the development of in-patient behavioural health services in Southeast Asia. Prior to that, he served as Vice President of strategic alliance development for Charter Behavioral Health Systems, among other key leadership positions in the healthcare industry.

Elizabeth Koury is Vice President of scientific affairs at LabConnect. She is responsible for leading a team of scientists, sample management professionals, and contract managers strategically supporting clients within the pharma industry. Elizabeth earned a bachelorís degree in biology/allied health from Elizabethtown College, US, and a masterís degree in pharmaceutical chemistry from Lehigh University, US. She has more than 20 years of experience in conducting and overseeing scientific research in the areas of neuroscience, oncology, and immunology.
spacer
Jeff Mayhew
spacer
spacer
spacer
Elizabeth Koury
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinerion expands team and moves to new headquarters in Basel

Clinerion is moving to new offices in Basel, Switzerland. Following strong expansion in its business, the company is in the process of growing its global team. In the six months leading up to the start of 2019, the company expects to have added several additional new positions. Staffing is increasing in all areas of the company, from Customer Solutions to Site & Patient Network Development, from Software Development to Data Analytics and Marketing.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

 
Industry Events

10th Annual Summit for Clinical Ops Executives

18-21 February 2019, Hyatt Regency Orlando, Florida

Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including...
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement